Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Greater Sudbury
Clinical trial register · Canada

Clinical Trials in Greater Sudbury, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6567 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:20 UTC
6567
Studies in scope
all four open statuses
3491
Recruiting now
open to new participants
883
Lead sponsors
across recruiting studies
Top sites
Toronto 2824 Montreal 1918 Vancouver 1190 Calgary 1067 Edmonton 1024
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca10 Canadian Cancer Trials Group9 AbbVie6 GlaxoSmithKline3 MeiraGTx, LLC3 Pfizer3 National Cancer Institute (NCI)3 Novartis Pharmaceuticals2 Merck Sharp & Dohme LLC2 Ontario Clinical Oncology Group (OCOG)2 Sunnybrook Health Sciences Centre2 Colorado Prevention Center2 Radiation Therapy Oncology Group2 Ottawa Hospital Research Institute2 Hoffmann-La Roche2 Inmagene LLC2 Eli Lilly and Company2 Population Health Research Institute2 Regeneron Pharmaceuticals1 University Health Network, Toronto1 David Palma1 Cytokinetics1 Ottawa Heart Institute Research Corporation1 University of Maryland, Baltimore1 ModernaTX, Inc.1 Show all 43
Site location
Toronto2824 Montreal1918 Vancouver1190 Calgary1067 Edmonton1024 Ottawa884 London880 Hamilton813 Québec685 Halifax534 Winnipeg455 Sherbrooke269 Kingston255 Kelowna177 Brampton144 Surrey141 Victoria129 St. John's127 Barrie126 Saskatoon125 Chicoutimi100 Moncton93 Mississauga89 Greater Sudbury84 Regina82 Show all 249
All 249 locations
Target enrolment
to

Trials with a site in Greater Sudbury

84 of 6567 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Not yet open
Sunnybrook Health Sciences Centre
Not applicable
480
Greater Sudbury, Toronto
2026-10
Recruiting
Pelage Pharmaceuticals, Inc.
Phase 2/3
600
Greater Sudbury, Oakville, Peterborough, Richmond Hill, Montreal, Sherbrooke
2026-09-21
Recruiting
Head of Bed After Ischemic Stroke Thrombectomy (HoBIT)
NCT07367633Large Vessel Occlusion, Stroke, Ischemic Stroke
Population Health Research Institute
Not applicable
2,240
Greater Sudbury, Hamilton
2026-09-03
Recruiting
AstraZeneca
Phase 3
2,800
Calgary, Edmonton, Winnipeg, Halifax, Brampton, Greater Sudbury, London, Mississauga
2026-09-01
Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis
DrugPALI-2108
Palisade Bio
Phase 2
204
Calgary, Edmonton, Greater Sudbury, London, Scarborough Village, Montreal
2026-08-28
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Barrie, Etobicoke, Greater Sudbury, Hamilton, Kingston, London, Markham, Newmarket
2026-08-24
By invitation
Implementation of Acute Heart Failure Checklist
NCT07727304Acute Heart Failure (AHF), Implementation Research
Ottawa Hospital Research Institute
Not applicable
5,040
Edmonton, Vancouver, Greater Sudbury, Kingston, London, Ottawa, Toronto
2026-08-15
Recruiting
ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
NCT07687056Stroke, Acute Ischemic, Endovascular Thrombectomy, Acute Ischemic Stroke AIS
DrugTenecteplase
University of Calgary
Phase 3
1,500
Calgary, Edmonton, Kelowna, New Westminster, Vancouver, Winnipeg, Greater Sudbury, Ottawa
2026-08-11
By invitation
Inmagene LLC
Phase 2
400
Surrey, Vancouver, Greater Sudbury, Mississauga, North Bay, Montreal, Saskatoon
2026-06-05
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Greater Sudbury, Halifax, London
2026-03-26
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Calgary, Vancouver, Brampton, Greater Sudbury, Toronto, Montreal, Sherbrooke, Québec
2026-03-23
Recruiting
Regeneron Pharmaceuticals
Phase 2
1,200
Edmonton, Victoria, Moncton, Greater Sudbury, Hamilton, Oshawa, Scarborough Village, Longueuil
2025-10-20
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Calgary, Vancouver, Québec, Halifax, Greater Sudbury, Hamilton, London, Mississauga
2025-10-02
Recruiting
Sanofi
Phase 3
980
Oakville, Brampton, Edmonton, Greater Sudbury, Hamilton, London, Montreal, New Westminster
2025-10-01
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Brampton, Burlington, Cambridge, Chicoutimi, Edmonton, Etobicoke, Greater Sudbury, Laval
2025-09-06
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Paraplatin
Merck Sharp & Dohme LLC
Phase 3
2,400
Surrey, Vancouver, St. John's, Barrie, Greater Sudbury, Oshawa, Ottawa, Sault Ste. Marie
2025-06-30
Recruiting
Pfizer
Phase 2
620
Richmond, Halifax, Greater Sudbury, Sarnia, Toronto, Winchester, Chicoutimi, Québec
2025-06-19
Recruiting
Inmagene LLC
Phase 2
405
Surrey, Vancouver, Greater Sudbury, Mississauga, North Bay, Montreal, Saskatoon
2025-06-17
Recruiting
Canadian Cancer Trials Group
Phase 3
830
Edmonton, Vancouver, Winnipeg, Saint John, Greater Sudbury, Hamilton, Kingston, Kitchener
2025-05-28
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
London, Toronto, Chicoutimi, Montreal, Greater Sudbury
2025-05-27
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Cambridge, Greater Sudbury, Hamilton, Kitchener, Mississauga, Oakville, Oshawa, Peterborough
2025-05-20
Recruiting
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
NCT05784428Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy, Quality of Life
Robert Olson
Not applicable
598
Kelowna, Prince George, Surrey, Vancouver, Victoria, Greater Sudbury, Toronto
2025-04-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Calgary, Greater Sudbury, Mississauga, Toronto, Montreal
2025-04-09
Recruiting
AbbVie
Observational
700
Edmonton, Moncton, St. John's, Greater Sudbury, Kingston
2025-03-28
Recruiting
Modifying PEST for Psoriatic Arthritis Screening
NCT06382051Plaque Psoriasis, Psoriatic Arthritis
Novartis Pharmaceuticals
Not applicable
502
Calgary, Edmonton, Kelowna, Surrey, Winnipeg, Fredericton, Barrie, Greater Sudbury
2025-01-23
Recruiting
International Care Bundle Evaluation in Cerebral Hemorrhage Research
NCT06429332Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage, Stroke
Region Skane
Phase 4
3,500
Greater Sudbury, Hamilton, Ottawa
2025-01-07
Recruiting
AstraZeneca
Phase 3
1,160
Abbotsford British Columbia, Saint John, Sydney, Greater Sudbury, Hamilton, Kingston, Sault Ste. Marie, Montreal
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Saint John, Sydney, Greater Sudbury, Hamilton, Sault Ste. Marie, Montreal
2024-11-18
Active, closed
ModernaTX, Inc.
Phase 3
37,864
Calgary, Chicoutimi, Greater Sudbury, Guelph, Halifax, Kelowna, Lévis, London
2024-09-24
Recruiting
AbbVie
Phase 2
590
Calgary, Edmonton, Greater Sudbury, London, Vaughan, Montreal, Québec
2024-09-04
Recruiting
Colorado Prevention Center
Phase 3
2,600
Calgary, Edmonton, North Vancouver, Surrey, Victoria, Winnipeg, Greater Sudbury, Kingston
2024-08-20
By invitation
Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
NCT06544798Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
MeiraGTx, LLC
Phase 2
276
Greater Sudbury
2024-08-02
Active, closed
GlaxoSmithKline
Phase 3
10,212
Edmonton, New Westminster, Surrey, Vancouver, Victoria, Halifax, Truro, Greater Sudbury
2024-08-01
Recruiting
Colorado Prevention Center
Phase 3
1,500
Edmonton, Surrey, Greater Sudbury, London, North York, Toronto, Montreal, Sherbrooke
2024-07-09
Recruiting
GlaxoSmithKline
Phase 3
864
Greater Sudbury, Hamilton, Toronto, Montreal
2024-03-21
Active, closed
Pfizer
Phase 3
1,571
Calgary, Edmonton, Vancouver, Winnipeg, Barrie, Greater Sudbury, London, Mississauga
2023-11-08
Recruiting
AbbVie
Phase 3
1,500
Calgary, Edmonton, Surrey, Winnipeg, Barrie, Greater Sudbury, Hamilton, Markham
2023-10-11
Recruiting
University of Manitoba
Phase 3
4,000
Calgary, Grande Prairie, Nanaimo, Penticton, Vancouver, Winnipeg, St. John's, Greater Sudbury
2023-10-10
Active, closed
AstraZeneca
Phase 3
5,511
Calgary, Edmonton, Kelowna, North Vancouver, Barrie, Greater Sudbury, Kingston, Thunder Bay
2023-10-05
Recruiting
Ottawa Hospital Research Institute
Not applicable
14,400
Calgary, Winnipeg, Greater Sudbury, Hawkesbury, London, North Bay, Thunder Bay, Toronto
2023-09-18
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Halifax, Brampton, Greater Sudbury, Montreal, Québec
2023-09-18
Active, closed
Cytokinetics
Phase 3
500
Edmonton, Winnipeg, Greater Sudbury, Montreal, Halifax
2023-08-31
Active, closed
Pfizer
Phase 2
507
Winnipeg, Greater Sudbury, Hamilton, Mississauga, Toronto, Chicoutimi, Québec
2023-08-22
Active, closed
CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee
NCT05828810Revision Total Hip Arthroplasty (RTHA), Revision Total Knee Arthroplasty
Sunnybrook Health Sciences Centre
Not applicable
400
Barrie, Greater Sudbury, Toronto
2023-07-25
Active, closed
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
NCT05926765Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
MeiraGTx, LLC
Phase 2
290
Greater Sudbury, Québec, Toronto, Trois-Rivières
2023-06-13
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Edmonton, Winnipeg, Saint John, St. John's, Greater Sudbury, Hamilton, London, Ottawa
2023-04-17
Recruiting
Canadian Cancer Trials Group
Phase 3
510
Vancouver, Winnipeg, Greater Sudbury, Hamilton, Toronto, Montreal, Sherbrooke
2023-02-10
Active, closed
AstraZeneca
Phase 3
1,350
Saint John, Brampton, Greater Sudbury, Kitchener, Newmarket, Montreal, Saint-Jérôme, Saskatoon
2022-12-29
Active, closed
Evaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT Study
NCT05543720Heart Failure，Congestive, Mental Health (Depression), Diabetes Mellitus, Chronic Obstructive Pulmonary Disease
University Health Network, Toronto
Not applicable
350
Brampton, Greater Sudbury, Markham, Toronto
2022-10-17
Active, closed
Eli Lilly and Company
Phase 3
15,374
Brampton, Calgary, Chicoutimi, Courtice, Greater Sudbury, Halifax, Hamilton, Lévis
2022-10-11
Active, closed
Biogen
Phase 2/3
450
Calgary, Edmonton, Greater Sudbury, Ottawa, Sherbrooke
2022-09-13
Active, closed
Symptomatic Carotid Outcomes Registry
NCT05300737Carotid Stenosis, Ischemic Stroke, Transient Ischemic Attack
University of Maryland, Baltimore
Observational
114
Calgary, Edmonton, Vancouver, Winnipeg, Greater Sudbury, London, Montreal
2022-08-01
Active, closed
Transanal Irrigation for the Management of LARS
NCT05007015Low Anterior Resection Syndrome, Rectal Cancer
Jewish General Hospital
Not applicable
66
Vancouver, Victoria, Greater Sudbury, London, Toronto, Montreal, Québec
2022-01-15
Recruiting
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
NCT04754022Disorder, Heart, Postoperative, Cardiac Surgery
Unity Health Toronto
Not applicable
1,440
Edmonton, Kelowna, Vancouver, Saint John, Greater Sudbury, Hamilton, Kingston, Toronto
2021-11-01
Recruiting
The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial
NCT04284839Bleeding Post Cardiac Surgery, Indication for Anticoagulation
DrugsDOAC·Dabigatran·Edoxaban·Warfarin
Population Health Research Institute
Phase 3
3,500
Edmonton, Vancouver, Winnipeg, Saint John, St. John's, Greater Sudbury, Hamilton, Toronto
2021-07-18
Active, closed
Hypofractionated LocoRegional Radiotherapy in Breast Cancer
NCT04228991Breast Neoplasms, Radiotherapy, Lymphedema
Ontario Clinical Oncology Group (OCOG)
Phase 3
588
Calgary, Edmonton, Kelowna, Prince George, Vancouver, Victoria, Greater Sudbury, Hamilton
2021-02-10
Active, closed
Anthos Therapeutics, Inc.
Phase 2
1,287
Cambridge, Greater Sudbury, Oshawa, Greenfield Park, Montreal
2021-02-02
Active, closed
GlaxoSmithKline
Phase 2/3
758
Greater Sudbury, Kingston, Oshawa, Greenfield Park, Montreal
2020-12-08
Active, closed
MeiraGTx, LLC
Observational
22
Greater Sudbury
2020-11-12
Active, closed
AstraZeneca
Phase 3
640
Barrie, Greater Sudbury
2020-10-19
Active, closed
Canadian Cancer Trials Group
Phase 2/3
53
Edmonton, Vancouver, Greater Sudbury, Hamilton, Kingston, Ottawa, Sault Ste. Marie, Toronto
2020-05-26
Active, closed
Canadian Cancer Trials Group
Not applicable
409
Victoria, Winnipeg, Halifax, Barrie, Greater Sudbury, Hamilton, Kingston, Mississauga
2019-11-15
Active, closed
Canadian Cancer Trials Group
Phase 2
82
Calgary, Edmonton, Vancouver, Greater Sudbury, Hamilton, Kingston, London, Newmarket
2019-10-25
Active, closed
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
NCT03914612Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma
DrugsParaplatin·Taxol·Keytruda·Paclitaxel
National Cancer Institute (NCI)
Phase 3
813
Moncton, Barrie, Greater Sudbury, Hamilton, Kingston, London, Oshawa, Sault Ste. Marie
2019-08-22
Active, closed
David Palma
Phase 3
204
Victoria, Halifax, Greater Sudbury, Kitchener, London, Mississauga, St. Catharines, Toronto
2019-02-22
Active, closed
AstraZeneca
Phase 3
1,407
Calgary, Barrie, Greater Sudbury, Toronto, Montreal, Québec, Rimouski
2019-01-04
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Calgary, Edmonton, Kelowna, North Vancouver, Surrey, Vancouver, Halifax, Greater Sudbury
2018-12-07
Recruiting
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
NCT03536312Ascending Aortic Aneurysm Enlargement, Ascending Aorta Aneurysm
Ottawa Heart Institute Research Corporation
Not applicable
610
Calgary, Edmonton, Saint John, St. John's, Halifax, Greater Sudbury, Hamilton, London
2018-09-01
Active, closed
Canadian Cancer Trials Group
Phase 2
129
Edmonton, Winnipeg, Halifax, Greater Sudbury, Hamilton, Kingston, London, Ottawa
2018-05-28
Active, closed
AbbVie
Phase 3
1,336
Calgary, Edmonton, New Westminster, Vancouver, Victoria, Halifax, Greater Sudbury, Hamilton
2018-04-09
Active, closed
AbbVie
Phase 3
747
Calgary, Edmonton, New Westminster, Vancouver, Halifax, Greater Sudbury, London, North Bay
2018-03-21
Active, closed
AstraZeneca
Phase 2
154
Greater Sudbury, Hamilton, Newmarket, Toronto, Montreal
2018-03-16
Active, closed
Canadian Cancer Trials Group
Phase 2
301
Edmonton, Surrey, Vancouver, Fredericton, Moncton, Saint John, Cambridge, Greater Sudbury
2017-03-28
Active, closed
AbbVie
Phase 3
950
Calgary, Edmonton, Kelowna, Victoria, Greater Sudbury, Hamilton, Ottawa, Vaughan
2017-01-31
Recruiting
Duration of Anti-PD-1 Therapy in Metastatic Melanoma
NCT02821013Unresectable/Metastatic Melanoma
Canadian Cancer Trials Group
Phase 3
614
Edmonton, Surrey, Vancouver, Victoria, Fredericton, Barrie, Greater Sudbury, Hamilton
2016-10-31
Active, closed
NRG Oncology
Phase 3
782
Calgary, Greater Sudbury, Montreal, Sherbrooke, Regina
2015-07-26
Active, closed
AstraZeneca
Phase 3
1,118
Greater Sudbury, Kingston, Newmarket, Oshawa, Saint Catherines, Sault Ste. Marie, Toronto, Regina
2015-07-21
Active, closed
Economic Analysis of Alliance A041202 CLL Study
NCT02414022Chronic Lymphocytic Leukemia
Canadian Cancer Trials Group
Observational
55
Calgary, Moncton, Greater Sudbury, Hamilton, Kingston, London, Newmarket, Ottawa
2015-04-15
Active, closed
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
NCT01886872Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
DrugsRituximab-pvvr·Riabni·Ruxience·Truxima
National Cancer Institute (NCI)
Phase 3
547
Calgary, Moncton, Halifax, Greater Sudbury, Hamilton, Kingston, London, Newmarket
2014-01-15
Active, closed
Ontario Clinical Oncology Group (OCOG)
Observational
500
Calgary, Abbotsford British Columbia, Prince George, Vancouver, Victoria, Winnipeg, Barrie, Greater Sudbury
2013-07
Active, closed
Prostate Advances in Comparative Evidence
NCT01584258Prostate Cancer
Royal Marsden NHS Foundation Trust
Phase 3
2,205
Greater Sudbury, Hamilton, London, Niagara, Oshawa, Ottawa, Toronto, Montreal
2012-08-07
Active, closed
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
NCT01274338Melanoma of Unknown Primary, Recurrent Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7
DrugsUrifron·Yervoy·Ipilimumab
National Cancer Institute (NCI)
Phase 3
1,673
Edmonton, Winnipeg, Greater Sudbury, Kitchener, Ottawa, Toronto, Montreal
2011-06-17
Active, closed
Radiation Therapy Oncology Group
Phase 2
252
Edmonton, Greater Sudbury, London, Toronto, Montreal
2011-01
Active, closed
Radiation Therapy Oncology Group
Phase 3
702
Edmonton, Winnipeg, St. John's, Greater Sudbury, London, Ottawa, Toronto, Montreal
2010-03-31
Rows per page Showing 1–84 of 84
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-canada/city/greater-sudbury

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,567 studies in total at the last sync on 13 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 84 of those studies with a site in Greater Sudbury.

How many clinical trials are recruiting in Greater Sudbury?

38 of the 84 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:20 UTC sync. A further 1 have not yet opened recruitment, 42 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Greater Sudbury), 84 studies
PhaseStudiesRecruitingShare
Phase 3442152.4%
Phase 217720.2%
Not applicable13715.5%
Observational516%
Phase 2/3414.8%
Phase 4111.2%

Most active sponsors

Lead sponsors with the most studies (Greater Sudbury)
Lead sponsorStudiesRecruiting
AstraZeneca104
Canadian Cancer Trials Group93
AbbVie63
GlaxoSmithKline31
MeiraGTx, LLC30
National Cancer Institute (NCI)30
Pfizer31
Colorado Prevention Center22
Eli Lilly and Company21
Hoffmann-La Roche21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.